the san francisco neurological society for basic research analyst of the disease, and the 2005 john douglas foundation award, and he was a key member of the expert panel. >> thank you for that very kind introduction. i think that when time is limited, i want to really provide a different perspective about alzheimer's disease to you. i spend most of my time taking care of people with alzheimer's disease and other forms of dementia, and the other part of my time is really spent trying to find new treatments and new ways to diagnose alzheimer's disease and dimension. i think many of us in the clinical research community feel that while these are terrible times financially in this country and these are tough times for care givers, there's a lot of hope that we can really look to in the research, i think, and i believe, and maybe i am a bit optimistic, but i think there's a good chance that in 10 years, when we are well into implementing this new plan for the city, we are going to have new ways to diagnose alzheimer's disease. we are going to do it earlier, more accurately, and we will also have